Tags : T-VIVA-19

Sorrento Selects T-VIVA-19 as a Targeted Protein Vaccine Candidate Against

Tuba Khan July 2, 2020

Shots: The company has published the preclinical data from its COVID-19 vaccination program, leading to the introduction of T-VIVA-19 as novel targeted protein vaccine If approved, Sorrento will deploy its […]readmore

Tags : T-VIVA-19

Sorrento Selects T-VIVA-19 as a Targeted Protein Vaccine Candidate Against

Latest Posts

PharmaShots Weekly Snapshots (November 15 – 19, 2021)

Jazz’ Sunosi (solriamfetol) Receives NICE Recommendation for the Treatment of Excessive Daytime Sleepiness Caused by Narcolepsy

Antengene’s Selinexor (ATG-010) Receives NMPA’s IND Approval for P-I/II SWATCH Study to Treat Non-Hodgkin Lymphoma

Daiichi Sankyo Reports Results of Quizartinib in P-III QuANTUM-First Trial for the Treatment of FLT3-ITD Positive AML

Company

Tags : T-VIVA-19

Sorrento Selects T-VIVA-19 as a Targeted Protein Vaccine Candidate Against

Latest Posts

PharmaShots Weekly Snapshots (November 15 – 19, 2021)

Jazz’ Sunosi (solriamfetol) Receives NICE Recommendation for the Treatment of Excessive Daytime Sleepiness Caused by Narcolepsy

Antengene’s Selinexor (ATG-010) Receives NMPA’s IND Approval for P-I/II SWATCH Study to Treat Non-Hodgkin Lymphoma

Daiichi Sankyo Reports Results of Quizartinib in P-III QuANTUM-First Trial for the Treatment of FLT3-ITD Positive AML

Categories

Related Topics

Company